Literature DB >> 26183700

Ketamine inside neurons?

Henry A Lester1, Luke D Lavis1, Dennis A Dougherty1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26183700      PMCID： PMC6107348          DOI： 10.1176/appi.ajp.2015.14121537

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  30 in total

1.  Selective esterase-ester pair for targeting small molecules with cellular specificity.

Authors:  Lin Tian; Yunlei Yang; Laura M Wysocki; Alma C Arnold; Amy Hu; Balaji Ravichandran; Scott M Sternson; Loren L Looger; Luke D Lavis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-12       Impact factor: 11.205

2.  Quantitative modeling of selective lysosomal targeting for drug design.

Authors:  Stefan Trapp; Gus R Rosania; Richard W Horobin; Johannes Kornhuber
Journal:  Eur Biophys J       Date:  2008-05-27       Impact factor: 1.733

Review 3.  Commentary. Lysosomotropic agents.

Authors:  C de Duve; T de Barsy; B Poole; A Trouet; P Tulkens; F Van Hoof
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

4.  An innovative design to establish proof of concept of the antidepressant effects of the NR2B subunit selective N-methyl-D-aspartate antagonist, CP-101,606, in patients with treatment-refractory major depressive disorder.

Authors:  Sheldon H Preskorn; Bryan Baker; Sheela Kolluri; Frank S Menniti; Michael Krams; Jaren W Landen
Journal:  J Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.153

5.  Mechanisms underlying differential effectiveness of memantine and ketamine in rapid antidepressant responses.

Authors:  Erinn S Gideons; Ege T Kavalali; Lisa M Monteggia
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

6.  Postsynaptic decoding of neural activity: eEF2 as a biochemical sensor coupling miniature synaptic transmission to local protein synthesis.

Authors:  Michael A Sutton; Anne M Taylor; Hiroshi T Ito; Anh Pham; Erin M Schuman
Journal:  Neuron       Date:  2007-08-16       Impact factor: 17.173

Review 7.  A synaptic trek to autism.

Authors:  Thomas Bourgeron
Journal:  Curr Opin Neurobiol       Date:  2009-06-21       Impact factor: 6.627

8.  Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors.

Authors:  Ruin Moaddel; Galia Abdrakhmanova; Joanna Kozak; Krzysztof Jozwiak; Lawrence Toll; Lucita Jimenez; Avraham Rosenberg; Thao Tran; Yingxian Xiao; Carlos A Zarate; Irving W Wainer
Journal:  Eur J Pharmacol       Date:  2012-11-23       Impact factor: 4.432

9.  Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  J Pharmacol Exp Ther       Date:  1985-12       Impact factor: 4.030

10.  GluN2B-containing NMDA receptors regulate depression-like behavior and are critical for the rapid antidepressant actions of ketamine.

Authors:  Oliver H Miller; Lingling Yang; Chih-Chieh Wang; Elizabeth A Hargroder; Yihui Zhang; Eric Delpire; Benjamin J Hall
Journal:  Elife       Date:  2014-10-23       Impact factor: 8.140
View more
  11 in total

1.  Ketamine: NMDA Receptors and Beyond.

Authors:  Charles F Zorumski; Yukitoshi Izumi; Steven Mennerick
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

2.  The Role of GluN2C-Containing NMDA Receptors in Ketamine's Psychotogenic Action and in Schizophrenia Models.

Authors:  Elizaveta Khlestova; Jon W Johnson; John H Krystal; John Lisman
Journal:  J Neurosci       Date:  2016-11-02       Impact factor: 6.167

Review 3.  Ketamine Action on Astrocytes Provides New Insights into Rapid Antidepressant Mechanisms.

Authors:  Matjaž Stenovec; Baoman Li; Alexei Verkhratsky; Robert Zorec
Journal:  Adv Neurobiol       Date:  2021

Review 4.  Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.

Authors:  Saurabh S Kokane; Ross J Armant; Carlos A Bolaños-Guzmán; Linda I Perrotti
Journal:  Behav Brain Res       Date:  2020-02-13       Impact factor: 3.332

Review 5.  KETAMINE'S MECHANISM OF ACTION: A PATH TO RAPID-ACTING ANTIDEPRESSANTS.

Authors:  Chadi G Abdallah; Thomas G Adams; Benjamin Kelmendi; Irina Esterlis; Gerard Sanacora; John H Krystal
Journal:  Depress Anxiety       Date:  2016-04-06       Impact factor: 6.505

6.  Ketamine-Based Anesthetic Protocols and Evoked Potential Monitoring: A Risk/Benefit Overview.

Authors:  Nicoleta Stoicea; Gregory Versteeg; Diana Florescu; Nicholas Joseph; Juan Fiorda-Diaz; Víctor Navarrete; Sergio D Bergese
Journal:  Front Neurosci       Date:  2016-02-16       Impact factor: 4.677

7.  A Clickable Analogue of Ketamine Retains NMDA Receptor Activity, Psychoactivity, and Accumulates in Neurons.

Authors:  Christine Emnett; Hairong Li; Xiaoping Jiang; Ann Benz; Joseph Boggiano; Sara Conyers; David F Wozniak; Charles F Zorumski; David E Reichert; Steven Mennerick
Journal:  Sci Rep       Date:  2016-12-16       Impact factor: 4.379

8.  Determining the pharmacokinetics of nicotinic drugs in the endoplasmic reticulum using biosensors.

Authors:  Amol V Shivange; Philip M Borden; Anand K Muthusamy; Aaron L Nichols; Kallol Bera; Huan Bao; Ishak Bishara; Janice Jeon; Matthew J Mulcahy; Bruce Cohen; Saidhbhe L O'Riordan; Charlene Kim; Dennis A Dougherty; Edwin R Chapman; Jonathan S Marvin; Loren L Looger; Henry A Lester
Journal:  J Gen Physiol       Date:  2019-02-04       Impact factor: 4.086

9.  Non-canonical Targets Mediating the Action of Drugs of Abuse: Cocaine at the Sigma-1 Receptor as an Example.

Authors:  Tsung-Ping Su
Journal:  Front Neurosci       Date:  2019-07-23       Impact factor: 4.677

10.  Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.

Authors:  S-X Li; Y Han; L-Z Xu; K Yuan; R-X Zhang; C-Y Sun; D-F Xu; M Yuan; J-H Deng; S-Q Meng; X-J Gao; Q Wen; L-J Liu; W-L Zhu; Y-X Xue; M Zhao; J Shi; L Lu
Journal:  Mol Psychiatry       Date:  2017-04-25       Impact factor: 15.992
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.